Clindamycin Palmitate Oral Suspension 75mg/5mL from Canada
Pediatric oral suspension with clindamycin palmitate hydrochloride at 75mg per 5mL after reconstitution, for treating infections in children. HTS 3004.20.00.55 applies as it contains clindamycin salts in retail measured doses.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide reconstitution instructions and pediatric dosing info on labels for FDA clearance
• Ensure powder form stability; declare shelf-life post-mixing
• Separate from adult formulations to match statistical reporting